Novel Coronavirus (SARS-CoV-2/COVID-19)
This week President Joe Biden used executive orders, memorandums and directives to fight the coronavirus pandemic.
In a study of 792 patients in six countries, the addition of intravenous arthritis drugs to standard care for COVID-19 patients in intensive care reduced the relative risk of death by 24%.
A study of more than 1,700 patients diagnosed with COVID-19 in Wuhan, China, in the first half of 2020 found 76% had at least one lingering symptom of the disease six months later.
Scientists have developed a COVID-19 antibody test so sensitive it can predict whether a patient will experience mild or severe symptoms of the disease.
The United States needs to use “innovative behavioral science and social marketing approaches to increase COVID-19 vaccine confidence and acceptance in diverse populations,” according to a recent editorial in JAMA.
In a Jan. 7 letter, the American Hospital Association (AHA) urged the Department of Health and Human Services (HHS) to take steps to speed COVID-19 vaccinations. “In the first few weeks of administering vaccines, hospitals have seen a number of barriers to smooth and effective vaccinations
To elicit more public gratitude for nurses, The DAISY Foundation kicked off a billboard campaign in New York City’s Time Square this month.
A protocol reduced episodes of self-harm among at-risk patients in one large, urban emergency department (ED) by more than half, according to a study in this month’s Journal on Quality and Patient Safety.
To support the “Thank a Nurse, Wear a Mask” campaign to promote safe behaviors that reduce the spread of COVID-19
A framework developed during the pandemic helped inform decision-making on when to curtail non-COVID-19 procedures at HCA Healthcare in Nashville, Tenn., according to former American hospital Association (AHA) Board Chair Jonathan Perlin M.D., president, clinical operations, and chief medical…